Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program

PURPOSE: Data on the safety of growth hormone (GH) replacement therapy during pregnancy are limited. We report a combined analysis of data from pregnant women treated with GH while enrolled in two non-interventional, multicenter studies: NordiNet® International Outcome Study (IOS) and the American N...

Descripción completa

Detalles Bibliográficos
Autores principales: Biller, Beverly M. K., Höybye, Charlotte, Carroll, Paul, Gordon, Murray B., Birkegård, Anna Camilla, Kelepouris, Nicky, Nedjatian, Navid, Weber, Matthias M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270875/
https://www.ncbi.nlm.nih.gov/pubmed/33709288
http://dx.doi.org/10.1007/s11102-021-01138-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270875/
https://www.ncbi.nlm.nih.gov/pubmed/33709288
http://dx.doi.org/10.1007/s11102-021-01138-3

Ejemplares similares